Back to News
Market Impact: 0.7

CCJ vs. URG: Which Uranium Stock is the Better Buy Today?

CCJURGNDAQ
Energy Markets & PricesCommodities & Raw MaterialsCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsRegulation & Legislation
CCJ vs. URG: Which Uranium Stock is the Better Buy Today?

The global uranium market is experiencing a bullish resurgence, with prices exceeding $80/pound, driven by ambitious nuclear power expansion plans (e.g., US aiming to quadruple capacity by 2050) and strategic reserve initiatives. In this environment, Cameco (CCJ) reported robust H1 2025 financials, including 35% revenue growth and a 248% adjusted EPS increase, underpinned by its diversified operations, tier-one assets, and fixed-price contracts, offering earnings visibility and stability despite a premium valuation. In contrast, Ur-Energy (URG), a smaller pure-play producer, faces near-term losses and volatility, though it projects substantial revenue growth for 2026 as its Shirley Basin project comes online, with analysts currently recommending Cameco for stability and growth.

Analysis

The uranium sector is exhibiting strong bullish fundamentals, with spot prices exceeding $80 per pound, driven by significant global nuclear capacity expansion targets in the U.S. and India, and policy initiatives like the U.S. strategic reserve increase. Within this context, Cameco (CCJ) demonstrates robust operational and financial health. For the first half of 2025, CCJ reported a 35% year-over-year revenue increase to CAD 1.67 billion and a 248% surge in adjusted earnings per share, largely insulated from spot price volatility by its fixed-price contracts and a 56% revenue growth in its fuel services segment. The company's 49% stake in Westinghouse provides a substantial, growing earnings stream, with projected adjusted EBITDA of $525-$580 million for 2025. In contrast, Ur-Energy (URG) presents as a smaller pure-play with a higher-risk profile. While its H1 2025 revenue grew 124% to $10.4 million, it remains unprofitable, posting a loss of $0.07 per share. URG's investment thesis hinges on future growth, specifically the Shirley Basin project coming online in 2026, which is forecast to drive a 336.5% revenue increase for that year. However, near-term forecasts are weak, with a projected 7.5% revenue decline in 2025 and downward revisions to analyst earnings estimates for both 2025 and 2026. This divergence is reflected in valuations: CCJ trades at a premium forward price-to-sales multiple of 15.00X after a 69% year-to-date gain, while URG trades at 5.72X, reflecting its speculative nature.